U.S. Entertainment Stock News

If you are looking at Halozyme Therapeutics and wondering whether the current share price reflects its true worth, this breakdown will help you make sense of what you are paying for. The stock recently closed at US$62.13, with returns of 1.2% decline over 7 days, 10.6% decline over 30 days, 11.6% decline year to date and 2.6% decline over 1 year, set against gains of 60.4% over 3 years and 44.7% over 5 years. Recent coverage has focused on how the share price has moved over different time...

If you are wondering whether Kinsale Capital Group's current share price still reflects good value, the recent moves in the stock give you plenty to think about. The shares last closed at US$336.69, with a 2.6% gain over the past week, set against declines of 13.6% over 30 days, 14.2% year to date and 30.7% over the past year. These price moves have kept Kinsale on the radar for investors who track longer term return profiles, with the stock showing 12.2% over 3 years and 99.1% over 5 years...

Recently, BioMarin Pharmaceutical discontinued three Phase 2 Voxzogo studies following safety concerns, while simultaneously reporting encouraging clinical and real-world outcomes for the drug in other settings. The company and analysts now suggest that Voxzogo’s safety issues may be limited to specific uses, with BioMarin’s broader outlook increasingly supported by its wider rare-disease portfolio. Now we’ll explore how the Voxzogo safety-driven trial discontinuations, alongside positive...

Wondering if Netflix at around US$92.97 is a bargain or a trap? This article breaks down what that price really implies about the business. The stock has been relatively flat over the last year with a return of around a 0.3% decline, while the 3 year return of 166.9% and 5 year return of 72.0% show how different the picture can look over longer periods. Recent coverage around Netflix has focused on its position as a major streaming platform and how shifts in subscriber expectations,...

Gibraltar Industries (ROCK) has been drawing attention after a period of weaker share performance, with the stock showing declines over the past month, past 3 months, year to date and over the past year. See our latest analysis for Gibraltar Industries. At a share price of $39.50, Gibraltar Industries has seen momentum fade, with a 30 day share price return of 13.15% and a 1 year total shareholder return of 32.66% in decline. If weak recent share price returns have you reassessing your...

Kroger (KR) has recently introduced in-store price cuts and expanded fuel savings events as gas prices climb, putting its approach to customer value and traffic front and center for investors watching the stock. See our latest analysis for Kroger. The recent price cuts and fuel savings push come at a time when the share price has shown firm momentum, with a 30 day share price return of 8.03% and a 90 day share price return of 17.61%. The 5 year total shareholder return of 123.20% reflects a...

CIM Real Estate Finance Trust (OTCPK:CMRF) has wrapped up FY 2025 with fourth quarter revenue of US$97.9 million and basic EPS of US$0.07, giving investors a clean snapshot of how the year finished. Over recent periods, revenue has shifted from US$121.4 million in Q3 2024 to US$106.2 million in Q4 2024, then to US$106.4 million in Q1 2025, US$107.2 million in Q2 2025, US$104.5 million in Q3 2025 and US$97.9 million in Q4 2025, while quarterly EPS moved from US$0.02 to an interim loss before...

If you are wondering whether Altria Group's current share price still reflects good value or if most of the upside has already been priced in, this breakdown is designed to give you a clear, structured view of what you are really paying for. With the stock at US$67.02 and returns of 4.1% over 7 days, a 2.9% decline over 30 days, 16.9% year to date and 19.5% over 1 year, recent moves suggest shifting views on both opportunity and risk. Recent coverage has continued to focus on Altria's...

On March 25, 2026, Raymond James analyst Justin Jenkins upgraded CVR Energy (NYSE: CVI) to Market Perform, highlighting the company’s refining portfolio as well positioned for a strong margin backdrop and acknowledging management’s optimism on refining demand and supply trends. This upgrade underscores how investor sentiment around refining exposure and perceived portfolio quality can play a meaningful role in how CVR Energy is viewed relative to its peers. Next, we’ll examine how this...

Ulta Beauty (NasdaqGS:ULTA) is expanding its K-Beauty World platform, giving viral Korean beauty brands faster access to the U.S. market. The company is doubling the number of e-commerce fulfillment stores and using AI tools to manage online orders and inventory. Brands that gain traction online, such as Dr. Melaxin, are moving quickly into nationwide in-store distribution across Ulta's network. Ulta Beauty operates as a multi brand beauty retailer, combining cosmetics, skincare, haircare,...

This article examines whether Compass at US$6.84 may represent attractive value or a potential value trap by exploring what the current price could be implying about the business. The stock has come under pressure recently, with a 19.2% decline over the last 7 days, 29.8% over 30 days, 34.9% year to date, and 21.6% over the past year, following a very large 3-year gain of 110.5% and a 5-year decline of 63.2%. Recent coverage has highlighted Compass as a real estate platform operating in a...

Wondering whether Viasat at around US$43.72 is still offering value or if most of the opportunity is already priced in? This article breaks down what the current share price might be implying. The stock has returned 16.2% year to date and 319.6% over the past year, even though the last 7 days and 30 days show declines of 11.1% and 4.5% respectively. Recent headlines have focused on Viasat's position in satellite communications and its role in providing connectivity services, which has kept...

If you are wondering whether Vistra's share price still reflects good value after its long run, or if the best days are already priced in, this article walks you through what the numbers say. The stock last closed at US$147.54, with returns showing a 2.5% decline over 7 days, a 15.2% decline over 30 days, a 10.7% decline year to date, and a 26.3% gain over the past year. The 3-year return is very large and the 5-year return is also very large. Recent moves in the share price have put more...

Silicon Motion Technology (SIMO) has drawn investor attention after recent price volatility, with the stock down about 18% over the past month but up roughly 17% in the past 3 months. See our latest analysis for Silicon Motion Technology. The recent 1 day share price decline of 4.19% and 7 day share price return of negative 14.77% sit against a much stronger 1 year total shareholder return of 113.94%. This suggests momentum has cooled in the short term after a powerful longer term run. If...

Array Technologies (ARRY) has been drawing attention after recent share price swings, with the stock at $6.88 and mixed returns across different periods, including a decline over the past 3 months and a 1-year total return above 40%. See our latest analysis for Array Technologies. The recent 1-day share price return of a 6.14% decline and 90-day share price return of a 26.81% decline contrast with a 1-year total shareholder return of 41.27%, suggesting earlier momentum has cooled in the short...

Bitmine Immersion Technologies (NYSEAM:BMNR) has expanded its MAVAN staking platform through the acquisition of the Pier Two infrastructure site. The move adds new validator infrastructure designed to support institutional scale Ethereum staking. This development goes beyond the initial MAVAN launch and ETH accumulation previously reported by the company. For you as an investor, this Pier Two acquisition moves NYSEAM:BMNR further into the Ethereum staking infrastructure business, with MAVAN...

Why Corning (GLW) is Back on Investors’ Radar Corning (GLW) has caught investor attention after a strong past 3 months, with a total return above 44%, even as the stock showed a 14% decline over the past month. See our latest analysis for Corning. The recent pullback in Corning’s share price, with a 1 month share price return of 15% and a 1 day move of 6% lower to US$128.55, follows a much stronger run earlier in the year. This included a 90 day share price return of 44.7% and a very large 1...

T. Rowe Price and Oak Hill Advisors recently launched the T. Rowe Price OHA Flexible Credit Income Fund (OFLEX), a publicly offered interval fund that invests across private and public credit markets and offers daily purchases with quarterly repurchase offers of at least 5% of outstanding shares at NAV. Alongside OFLEX, T. Rowe Price expanded its global retirement leadership team following a senior retirement executive’s planned exit, underscoring its focus on retirement solutions and...

In March 2026, Match Group agreed to settle a U.S. Federal Trade Commission lawsuit alleging OkCupid shared millions of users’ photos, demographic details, and location data with facial-recognition firm Clarifai in 2014 without proper disclosure, and must now certify stricter privacy compliance. The settlement underscores how data-handling practices and user privacy safeguards can directly influence regulatory risk, brand trust, and long-term platform engagement for Match Group’s...

If you are wondering whether Roku's current share price reflects its true worth, you are not alone; the stock's recent moves have raised fresh questions about what you are really paying for. Roku closed at US$88.23, with returns of a 9.8% decline over 7 days, a 10.3% decline over 30 days and an 18.8% decline year to date, set against a 25.3% gain over 1 year and 34.3% over 3 years, while the 5 year return stands at a 73.1% decline. Recent headlines around Roku have focused on its position in...

If you are wondering whether Alphatec Holdings at around US$11 is a bargain or a value trap, the key is to look past the headline share price and into how it stacks up on valuation. The stock has seen a 9.5% decline over the last week, a 19.2% decline over the last 30 days, and is down 47.0% year to date, even though the 1 year return sits at 8.5%. These moves sit against a backdrop of ongoing interest in medical equipment companies, with investors weighing up growth potential in specialist...

In March 2026, Agilent Technologies received U.S. Food and Drug Administration approval for its PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved companion diagnostic to identify esophageal or gastroesophageal junction carcinoma patients (CPS = 1) who may be eligible for Merck’s KEYTRUDA (pembrolizumab) combination therapy. This eighth KEYTRUDA-related indication for PD-L1 IHC 22C3 pharmDx strengthens Agilent’s role in precision oncology by broadening its companion diagnostic...

Box (BOX) has expanded its equity buyback plan, adding US$500 million in authorization to reach US$1.86b and extending the program through September 30, 2027. This move refocuses attention on capital returns. See our latest analysis for Box. At a share price of US$23.32, Box has a 90 day share price return of 23.31% and a one year total shareholder return of 24.43% decline, pointing to fading momentum even as the larger buyback program draws fresh attention from investors. If you are weighing...

With U.S. Bancorp around US$50.88, you might be wondering whether the current share price reflects solid value or if expectations have already been priced in. Over shorter periods the stock has been choppy, with a 1.2% decline over the last week and a 6.9% decline over the past month, while still showing a 25.6% return over 1 year and 64.2% over 3 years. Recent coverage has focused on how U.S. Bancorp fits into the broader U.S. banking sector and how investors are weighing interest rate...